Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Gezondheid en geneeskundeOne-Off2mnd
Manifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdWaarschuwing datakwaliteitBrongegevens verslechterd
Gegevens van 26 okt 2026, 17:11 UTC · beleid pm-quality-4
Huidige gemeenschapsvoorspelling
Nee 66.4%
Nee 66.4%Voorspellers
18
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 1 uur geleden
Vertraagd5 okt 24, 02:42 UTC2 jan 27, 04:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
Will the FDA approve any psychedelic substance for medical use this year?
KalshiWill the FDA approve any psychedelic substance for medical use before 2028?
KalshiWill MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
Manifold MarketsBy 2028 end, will there be AI-assisted therapy, where therapists visually explore a patient's thoughts/memories?
Manifold MarketsBy 2030, will the FDA approve any drug in combination with a checkpoint blockade therapy that substantially reduces immune escape?
Manifold MarketsWhen will the FDA approve Compass Pathways' COMP360 Psilocybin?
KalshiRegels
https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate
- Resolves YES if any currently known psychedelic substance (as of October 4th, 2024) is FDA approved for any category of mental disorder by January 1st 2027.
- The caveat is mainly to avoid the possibility that any subsequent drug development produces a treatment for a mental disorder that is later found out to have psychedelic effects.
- Possible clarification from creator (AI generated): Market will resolve as N/A if the FDA is abolished before January 1st 2027.
